Device Cmf-Trauma

Matrixrib

Payments companies reported to CMS as associated with Matrixrib. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1.2Massociated payments (2023-2025)

1,011clinicians with associated payments

5companies reporting

By year

2023 $468K

2024 $392K

2025 $338K

Payments reported as associated with Matrixrib, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthopaedic Surgery $664K

Trauma Surgery $168K

Surgical Critical Care $148K

Surgery $92K

Thoracic Surgery (Cardiothoracic Vascular Surgery) $87K

Physician Assistant $6,329

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Matrixrib

These are the largest totals companies reported as associated with Matrixrib. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Steven Madey	Lake Oswego, OR	Orthopaedic Surgery	$470,677.88
Daniel Fitzpatrick	Eugene, OR	Orthopaedic Surgery	$188,271.08
Evert Eriksson	Charleston, SC	Surgical Critical Care	$60,243.19
Zachary Warriner	Lexington, KY	Trauma Surgery	$53,997.03
William Long	Portland, OR	Trauma Surgery	$47,067.15
Ledford Powell	Laguna Hills, CA	Thoracic Surgery (Cardiothoracic Vascular Surgery)	$37,806.04
Nir Hus	Delray Beach, FL	Surgical Critical Care	$34,101.93
Gina Golden	Phoenix, AZ	Trauma Surgery	$29,906.70
Kurt Martinson	St Cloud, MN	Surgery	$29,422.45
Dudley Christie	Macon, GA	Surgical Critical Care	$26,947.20

Prescribed Matrixrib?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.